Literature DB >> 18088077

How hypoglycaemia can affect the life of a person with diabetes.

Brian M Frier1.   

Abstract

Hypoglycaemia is the commonest side-effect of insulin treatment for diabetes, and is the single greatest barrier to achieving and maintaining good glycaemic control. Severe hypoglycaemia (requiring assistance for recovery) is associated with significant morbidity and is feared by most people with type 1 diabetes and their families. It causes stress and anxiety and may influence self-management and glycaemic control. The annual prevalence of severe hypoglycaemia is around 30% in people with type 1 diabetes, and is higher in those with risk factors such as strict glycaemic control, impaired awareness of hypoglycaemia and increasing duration of diabetes. It is also common during sleep (nocturnal hypoglycaemia). Neurological manifestations include coma, convulsions, transient hemiparesis and stroke, while reduced consciousness and cognitive dysfunction may cause accidents and injuries. Cardiac events may be precipitated such as arrhythmias, myocardial ischaemia and cardiac failure. Hypoglycaemia can affect all aspects of life, including employment, driving, recreational activities involving exercise, and travel, and measures should be taken in all of these situations to avoid this potentially dangerous side-effect of insulin therapy. Copyright (c) 2007 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18088077     DOI: 10.1002/dmrr.796

Source DB:  PubMed          Journal:  Diabetes Metab Res Rev        ISSN: 1520-7552            Impact factor:   4.876


  58 in total

1.  Cost Effectiveness of IDegLira vs. Alternative Basal Insulin Intensification Therapies in Patients with Type 2 Diabetes Mellitus Uncontrolled on Basal Insulin in a UK Setting.

Authors:  Melanie J Davies; Divina Glah; Barrie Chubb; Gerasimos Konidaris; Phil McEwan
Journal:  Pharmacoeconomics       Date:  2016-09       Impact factor: 4.981

2.  Acute hypoglycemia causes depressive-like behaviors in mice.

Authors:  Min Jung Park; Samuel W Yoo; Brian S Choe; Robert Dantzer; Gregory G Freund
Journal:  Metabolism       Date:  2011-08-04       Impact factor: 8.694

3.  Impaired awareness of hypoglycemia in a man with type 1 diabetes.

Authors:  Gilles Plourde; Agnes V Klein; Robert Dent
Journal:  CMAJ       Date:  2014-02-10       Impact factor: 8.262

4.  Insulin degludec U100 is associated with lower risk for severe and symptomatic hypoglycemia as compared with insulin glargine U100 in subjects with type 1 diabetes.

Authors:  Anastasios Tentolouris; Ioanna Eleftheriadou; Nikolaos Tentolouris
Journal:  Ann Transl Med       Date:  2018-02

5.  Assessing fear of hypoglycemia in children with Type 1 diabetes and their parents.

Authors:  Linda Gonder-Frederick; Maren Nyer; Jaclyn A Shepard; Karen Vajda; William Clarke
Journal:  Diabetes Manag (Lond)       Date:  2011

6.  Predicting and Preventing Nocturnal Hypoglycemia in Type 1 Diabetes Using Big Data Analytics and Decision Theoretic Analysis.

Authors:  Clara Mosquera-Lopez; Robert Dodier; Nichole S Tyler; Leah M Wilson; Joseph El Youssef; Jessica R Castle; Peter G Jacobs
Journal:  Diabetes Technol Ther       Date:  2020-05-14       Impact factor: 6.118

Review 7.  Practical steps to improving the management of type 1 diabetes: recommendations from the Global Partnership for Effective Diabetes Management.

Authors:  P Aschner; E Horton; L A Leiter; N Munro; J S Skyler
Journal:  Int J Clin Pract       Date:  2010-02       Impact factor: 2.503

Review 8.  Early sympathetic islet neuropathy in autoimmune diabetes: lessons learned and opportunities for investigation.

Authors:  Thomas O Mundinger; Gerald J Taborsky
Journal:  Diabetologia       Date:  2016-06-24       Impact factor: 10.122

Review 9.  Treating type 1 diabetes: from strategies for insulin delivery to dual hormonal control.

Authors:  A L McCall; L S Farhy
Journal:  Minerva Endocrinol       Date:  2013-06       Impact factor: 2.184

Review 10.  Continuous Glucose Monitoring: Impact on Hypoglycemia.

Authors:  Cornelis A J van Beers; J Hans DeVries
Journal:  J Diabetes Sci Technol       Date:  2016-11-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.